SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.87-2.3%Dec 5 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (336)8/2/1999 8:50:00 AM
From: LLCF  Read Replies (1) of 52153
 
Bloomberg- "Big Biotech Stocks Seen Rising as Index Approaches Record High"

"The Amex Biotech Index last week almost broke a record high set in January 1992, led by shares in Gilead, Corr, and Chiron, which are among the handful of the more than 300 publicly traded biotech companies that have succeeded in bringing products to market"-snip

On the bright side for those of us in the "money losing biotechs"-

"With a group like this that has fairly improving fundamentals, it's difficult to put tops on these stocks", said Joh Schroer, who manages about $3 billion in health-care stocks for Invesco.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News